Susan E. Kephart - Concepedia

Author

Susan E. Kephart

Pfizer (United States)

Also Known As

Kephart, Susan, Kephart, Susan E., S. E. KEPHART, S. E. Kephart, S. Kephart, Susan E. Kephart, Susan Kephart

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)WuXi AppTec (China)

About

Susan E. Kephart is an author at Pfizer (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	445
2	Natural Sciences	5	5	329
3	Biochemistry	4	4	215
4	Engineering	1	1	114
5	Cell Biology	1	1	172

Susan E. Kephart

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth Brion W. Murray, Chuangxing Guo, Joseph Piraino, Proceedings of the National Academy of Sciences	2010	318
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor Kevin D. Freeman‐Cook, Robert L. Hoffman, Nichol Miller, Cancer Cell Tumor BiologyOncologyCdk2/4/6 InhibitorMedicineTumor Cell Cycle	2021	172
Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (<i>R</i>)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (PF-06821497) Pei‐Pei Kung, Patrick Bingham, Alexei Brooun, Journal of Medicinal Chemistry	2017	125
Silicon-directed aldol reactions. Rate acceleration by small rings Andrew Myers, Susan E. Kephart, Hou Chen Journal of the American Chemical Society EngineeringChemical AnalysisAltmetric Attention ScoreOrganic ChemistryChemistry	1992	114
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer Kevin D. Freeman‐Cook, Robert L. Hoffman, Douglas C. Behenna, Journal of Medicinal Chemistry	2021	112
Systematic Structure Modifications of Imidazo[1,2-<i>a</i>]pyrimidine to Reduce Metabolism Mediated by Aldehyde Oxidase (AO) Angelica Linton, Ping Kang, Martha A. Ornelas, Journal of Medicinal Chemistry Androgen ReceptorBioorganic ChemistryMolecular BiologyPharmacotherapyChemical Biology	2011	80
Discovery of Aryloxy Tetramethylcyclobutanes as Novel Androgen Receptor Antagonists Chuangxing Guo, Angelica Linton, Susan E. Kephart, Journal of Medicinal Chemistry	2011	67
Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2 <i>H</i> )-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Pei‐Pei Kung, Eugene Rui, Simon Bergqvist, Journal of Medicinal Chemistry	2016	66
Discovery of Pyrroloaminopyrazoles as Novel PAK Inhibitors Chuangxing Guo, Indrawan McAlpine, Junhu Zhang, Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ChemistryBiochemistryMedicineTumor Growth	2012	59
Substituted Benzamide Inhibitors of Human Rhinovirus 3C Protease: Structure-Based Design, Synthesis, and Biological Evaluation Siegfried Reich, Theodore Johnson, Michael B. Wallace, Journal of Medicinal Chemistry Bioorganic ChemistryAntiviral DrugViral Structural ProteinChemical BiologyVirus Structure	2000	52

Page 1